Create Technology & Science Co Cash & Equivalents
The Cash & Short-Term Investments of Create Technology & Science Co (000551.SZ) as of Nov 10, 2026 is 1.25 B CNY. In the previous year, Cash & Short-Term Investments was 1.16 B CNY — a change of 7.16% (higher).
Get this data via API
Financial Data API
Cash & Equivalents
1.25 BCNY
YoY
7.16%
Last updated:
The Create Technology & Science Co Cash & Equivalents history
3 Years
10 Years
25 Years
Max
| YEAR | Cash & Equivalents | YoY |
|---|---|---|
| 1.25 BCNY | +7.16% | |
| 1.16 BCNY | -10.10% | |
| 1.29 BCNY | +32.43% | |
| 976.26 MCNY | -1.70% | |
| 993.16 MCNY | +5.62% | |
| 940.34 MCNY | +9.84% | |
| 856.13 MCNY | +4.83% | |
| 816.70 MCNY | +6.40% | |
| 767.55 MCNY | +54.83% | |
| 495.73 MCNY | +4.38% | |
| 474.92 MCNY | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Create Technology & Science Co Stock analysis
Frequently Asked Questions about Create Technology & Science Co stock
Cash & Short-Term Investments of Create Technology & Science Co is 1.25 B CNY in 2024.
Cash & Short-Term Investments of Create Technology & Science Co changed from 1.16 B CNY to 1.25 B CNY, representing a 7.16% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Cash & Short-Term Investments Create Technology & Science Co since 2006 – with annual values, charts, and detailed analysis.
Cash and equivalents represent the most liquid assets on the balance sheet, available for immediate use or short-term obligations.
Cash & Short-Term Investments's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cash & Short-Term Investments's Create Technology & Science Co historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Create Technology & Science Co
All Key Metrics — Create Technology & Science Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth